NCT03477591

Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions

McMaster Choices Study: Evaluating the Impact of Evidence-based Information About PSA Testing on Prostate Cancer Screening Decisions

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 308 (actual)
• Sponsor: McMaster University · Academic / Other
• Sex: Male
• Age: 50 Years
• Healthy volunteers: Accepted

Summary

Patient decision aids are tools that help guide individuals through a healthcare-related decision making process. They help users combine evidence-based information and recommendations by a health care provider with their personal needs, values and preferences. Through this project, Dr. Dobbins and her research team will explore whether the use of patient decision aids with high-quality and user-friendly summaries of research evidence, or summaries of research evidence alone, help to improve the quality of decision making by men facing prostate cancer screening decisions.

Detailed description

Guidelines for prostate screening in Canada are based on low-moderate quality evidence of effectiveness and screening is associated with potential harms. Patient Decision Aids (PDAs) are tools that assist users to understand treatment options, risks and benefits to align decisions with values and preferences. The investigators would now like to know whether use of a PDA alongside evidence-based information provided through the McMaster Optimal Aging Portal, or simply access to evidence-based information alone, can help users to make informed decisions about prostate cancer screening in men.

Conditions

• Prostate Cancer

Interventions

Type	Name	Description
OTHER	Evidence-based information	Evidence-based information on PSA testing such as blog posts, plain language evidence summaries and web resource ratings (quality-appraised online resources).
OTHER	Patient Decision Aid	Patient Decision Aid for prostate cancer screening decision
OTHER	Sham information	Educational information not specific to PSA testing or cancer screening

Timeline

• Start date: 2018-10-01
• Primary completion: 2019-08-30
• Completion: 2021-07-01
• First posted: 2018-03-26
• Last updated: 2023-10-19

Locations

1 site across 1 country: Canada